A device for use of a drug for treating lupus erythematosus

Abstract

This invention discloses a device for administering medication for lupus erythematosus, relating to the technical field of medication administration devices. The device includes a main body, with a syringe inserted into the right side of its internal cavity. A loading assembly is fixedly connected to the right side of the back of the main body. Limiting components are symmetrically and movably connected to the top and bottom of the back of the loading assembly's internal cavity. Movable blocks are symmetrically and fixedly connected to the center of the back of the two limiting components. A medicine box is fixedly connected to the left side of the back of the main body's internal cavity. A grinding assembly is movably connected to the left side of the top of the main body. A needle hole groove is formed on the left side of the front of the main body, and a baffle is movably connected to the front of the needle hole groove. This device for administering medication for lupus erythematosus has multiple functions, is easy to carry, and can hold various treatment devices according to the treatment method. It can also remind the patient to perform treatment.

Description

Technical Field

[0001] This invention relates to the field of drug application device technology, and in particular to a drug application device for the treatment of lupus erythematosus. Background Technology

[0002] Systemic lupus erythematosus (SLE) is a typical autoimmune connective tissue disease, most commonly affecting women aged 15 to 40. SLE is a spectrum disease, classified into subtypes such as discoid lupus erythematosus, subacute cutaneous lupus erythematosus, systemic lupus erythematosus, deep lupus erythematosus, neonatal lupus erythematosus, and drug-induced lupus erythematosus. Patients with lupus often need to carry large amounts of medication when out and about, but currently there is a lack of suitable devices for carrying and administering these medications, making it inconvenient when medication needs to be taken.

[0003] Chinese patent application CN202210883926.4 discloses a portable medication carrying device for oncology, comprising an upper canister and a lower canister. The top of the upper canister is a pressing part, the middle of the upper canister is a storage part, and the bottom of the upper canister is a connecting part. The lower canister is installed at the bottom of the connecting part of the upper canister. The storage part of the upper canister has multiple medicine boxes containing medications. The pressing part of the upper canister also has a squeezing structure, and the lower canister has a medication-holding structure. The squeezing structure and the medication-holding structure work together to grind the medication into powder. This invention has a simple structure, is convenient for patients to carry, and allows for quick access to medications. It can not only grind medications into powder but also directly dissolve the ground medication powder in water to form a liquid, and has the function of sucking and swallowing the liquid. This device is suitable for carrying and using the same medication.

[0004] When lupus patients are outdoors, they need to use different medications depending on their treatment plan. Currently, there is a lack of suitable medication delivery devices specifically designed for lupus patients. Therefore, it is essential to propose a medication delivery device for lupus treatment to solve the above problem. Summary of the Invention

[0005] In view of this, the main objective of the present invention is to provide a device for using a lupus erythematosus treatment drug, which can effectively solve the problems in the prior art.

[0006] To achieve the above objectives, the technical solution adopted by the present invention is as follows:

[0007] A device for administering a lupus erythematosus treatment drug includes a device body, a syringe inserted into the right side of the inner cavity of the device body, a loading component fixedly connected to the right side of the back of the device body, and limit components symmetrically and movably connected to the top and bottom of the back of the inner cavity of the loading component, with movable blocks symmetrically and fixedly connected to the center of the back of the two limit components.

[0008] A medicine box is fixedly connected to the left side of the back of the inner cavity of the device body, a grinding component is movably connected to the left side of the top of the device body, a pinhole groove is opened on the left side of the front of the device body, and a baffle is movably connected to the front of the pinhole groove.

[0009] Preferably, a threaded post is fixedly connected to the center of the front side of the loading component, and the threaded post is threaded to the back side of the device body. Both the loading component and the threaded post are hollow structures, and the back side of the syringe is located in the inner cavity of the loading component.

[0010] Preferably, the two limiting components are symmetrically fixedly connected with Velcro on opposite sides, and sterile wipes are symmetrically adhered to opposite sides of the two Velcro components. The opposite sides of the two sterile wipes are symmetrically attached to the back of the top and bottom of the syringe outer wall.

[0011] Preferably, the two movable blocks are symmetrically and movably connected to the top and bottom of the back side of the loading assembly cavity. A bidirectional lead screw is rotatably connected to the back side of the loading assembly cavity. A rotating handle is fixedly connected to the top of the bidirectional lead screw. The rotating handle is rotatably connected to the back side of the top of the loading assembly. The two movable blocks are symmetrically threaded to the top and bottom of the outer wall of the bidirectional lead screw.

[0012] Preferably, the top of the medicine box is movably connected to a lid, which is fastened to the top of the device body by a locking block. A buzzer is fixedly connected to the front right side of the device body, and a timer is fixedly connected to the back right side of the device body. A movable column is fixedly connected to the center of the bottom of the grinding component, and a grinding disc is fixedly connected to the bottom of the movable column. The grinding disc is movably connected to the left side of the inner cavity of the device body, and a medicine inlet is provided on the left side of the device body.

[0013] Preferably, a groove is provided on the left side of the front of the device body, the baffle is movably connected in the inner cavity of the groove, the pinhole slot is provided in the groove, and symmetrical moving slots are provided in the center of the top and bottom of the inner cavity of the groove. Guide posts are symmetrically fixedly connected in the center of the inner cavity of the two moving slots, and springs are symmetrically wound around the outer walls of the two guide posts. The right side of the spring is fixedly connected to the right side of the inner cavity of the moving slot. The right sides of the top and bottom of the baffle are symmetrically movably connected in the inner cavity of the two moving slots and sleeved on the outer walls of the two guide posts. The left sides of the two springs are symmetrically fixedly connected to the top and bottom of the right side of the baffle.

[0014] Beneficial effects

[0015] Compared with the prior art, the present invention has the following beneficial effects:

[0016] 1. The device for administering lupus treatment medication is designed to be portable for lupus patients, facilitating treatment. The included syringe allows for medication injection, and a limiting component enables the syringe to be installed normally. A sterilizing wipe allows for sterilization, and a threaded post facilitates the removal and cleaning of the loading component.

[0017] 2. The device for using lupus treatment medication includes a medicine box for holding the medication, a buzzer and timer to remind the user to take the medication, and a grinding component that rotates to grind the specific medication by rotating the grinding disc via a movable column, thus facilitating subsequent preparation and administration.

[0018] 3. The device for administering the lupus erythematosus treatment drug has a needle hole slot that allows the syringe needle to be placed inside the device, facilitating subsequent needle replacement. A spring keeps the baffle retracting to the right, blocking the needle hole slot in its normal state and preventing the needle from falling out during transport. Attached Figure Description

[0019] Figure 1 This is a schematic diagram of the front structure of the present invention;

[0020] Figure 2 This is a schematic diagram of the structure of the loading component of the present invention;

[0021] Figure 3 This is the present invention. Figure 1 Enlarged view of point A in the middle;

[0022] Figure 4 This is a schematic diagram of the structure of the grinding assembly of the present invention.

[0023] In the diagram: 1. Device body; 2. Buzzer; 3. Timer; 4. Syringe; 5. Loading assembly; 6. Threaded post; 7. Rotary handle; 8. Limiting assembly; 9. Velcro; 10. Disinfecting wipe; 11. Movable block; 12. Bidirectional lead screw; 13. Medicine box; 14. Grinding assembly; 15. Movable post; 16. Grinding disc; 17. Pull ring; 18. Baffle; 19. Pinhole groove; 20. Moving groove; 21. Guide post; 22. Spring. Detailed Implementation

[0024] To make the technical means, creative features, objectives and effects of this invention easier to understand, the invention will be further described below in conjunction with specific embodiments.

[0025] like Figure 1-2 As shown, a device for administering a lupus erythematosus treatment drug includes a device body 1. A syringe 4 is inserted into the right side of the inner cavity of the device body 1. A loading assembly 5 is fixedly connected to the right side of the back of the device body 1. Limiting components 8 are symmetrically and movably connected to the top and bottom of the back of the inner cavity of the loading assembly 5. Movable blocks 11 are symmetrically and fixedly connected to the center of the back of the two limiting components 8. A threaded post 6 is fixedly connected to the center of the front of the loading assembly 5. The threaded post 6 is threadedly connected to the back of the device body 1. Both the loading assembly 5 and the threaded post 6 are hollow structures. The back of the syringe 4 is disposed within the inner cavity of the loading assembly 5. A Velcro strap 9 is symmetrically fixed to the center of one side of the limiting component 8. A sterile towel 10 is symmetrically attached to one side of the two Velcro straps 9. The two sterile towels 10 are symmetrically attached to the back of the top and bottom of the outer wall of the syringe 4. Two movable blocks 11 are symmetrically movable to the top and bottom of the back of the inner cavity of the loading component 5. A bidirectional lead screw 12 is rotatably connected to the back of the inner cavity of the loading component 5. A rotating handle 7 is fixedly connected to the top of the bidirectional lead screw 12. The rotating handle 7 is rotatably connected to the back of the top of the loading component 5. Two movable blocks 11 are symmetrically threaded to the top and bottom of the outer wall of the bidirectional lead screw 12.

[0026] The device body 1 allows lupus patients to carry it at any time for convenient treatment. The syringe 4 allows for drug injection. The limiting component 8 allows for the installation of the syringe 4 in normal operation. The disinfectant wipe 10 allows for disinfection. The threaded post 6 allows for easy removal of the loading component 5 for cleaning and disinfection.

[0027] like Figure 1 , 3As shown in Figure 4, a device for using a lupus erythematosus treatment drug includes a medicine box 13 fixedly connected to the left side of the back of the inner cavity of the device body 1; a grinding assembly 14 movably connected to the left side of the top of the device body 1; a pinhole slot 19 opened on the left side of the front of the device body 1; a baffle 18 movably connected to the front of the pinhole slot 19; a lid movably connected to the top of the medicine box 13, which is fastened to the top of the device body 1 by a locking block; a buzzer 2 fixedly connected to the front of the right side of the device body 1; a timer 3 fixedly connected to the back of the right side of the device body 1; a movable column 15 fixedly connected to the center of the bottom of the grinding assembly 14; a grinding disc 16 fixedly connected to the bottom of the movable column 15; and the grinding disc 16 movably connected to the device body. On the left side of the inner cavity, a drug inlet is provided on the left side of the device body 1. A groove is provided on the left side of the front of the device body 1. A baffle 18 is movably connected in the inner cavity of the groove. A needle hole outlet groove 19 is provided in the groove. Moving grooves 20 are symmetrically provided in the center of the top and bottom of the inner cavity of the groove. Guide posts 21 are symmetrically fixedly connected in the center of the inner cavity of the two moving grooves 20. Springs 22 are symmetrically wound on the outer walls of the two guide posts 21. The right side of the springs 22 is fixedly connected to the right side of the inner cavity of the moving grooves 20. The right side of the top and bottom of the baffle 18 is symmetrically movably connected in the inner cavity of the two moving grooves 20 and sleeved on the outer wall of the two guide posts 21. The left side of the two springs 22 is symmetrically fixedly connected to the top and bottom of the right side of the baffle 18.

[0028] The medicine box 13 can hold medication for treating lupus erythematosus. The buzzer 2 and timer 3 can remind the user to take the medication. By rotating the grinding component 14, the grinding disc 16 can be rotated via the movable column 15, thereby grinding specific medications for later preparation and consumption. The needle outlet groove 19 can hold the needle of the syringe 4 in its inner cavity, facilitating needle replacement. The spring 22 can retract the baffle 18 to the right at all times, so that the baffle 18 can cover the needle outlet groove 19 in the normal state, thus preventing the needle from falling out during carrying.

[0029] It should be noted that this invention is a device for administering a medication for lupus erythematosus. In use, the medicine box 13 is opened, the medication is placed in the inner cavity of the medicine box 13, and the pull ring 17 is moved to the left so that the baffle 18 can move away from the front of the needle outlet groove 19. A spare needle is placed into the inner cavity of the device body 1 through the needle outlet groove 19. After releasing the pull ring 17, the spring 22 causes the baffle 18 to retract, thereby blocking the needle outlet groove 19. When the syringe 4 is needed for medication injection, the handle 7 is rotated to drive the bidirectional lead screw 12 forward. The movement rotates, allowing the movable block 11 to connect with its thread, thereby causing the two limiting components 8 to disengage from the outer wall of the syringe 4. The needle is then removed from the inner cavity of the needle hole groove 19 and installed at the syringe 4. The medication is injected into the inner cavity of the syringe 4, and treatment can then begin. When special medications are required, they are placed at the bottom of the grinding disc 16, and the grinding component 14 is rotated and pressed down so that the grinding disc 16 can tightly adhere to the top of the medication and grind it. After grinding, the medication can be brewed and taken.

[0030] The foregoing has shown and described the basic principles, main features, and advantages of the present invention. Those skilled in the art should understand that the present invention is not limited to the above embodiments. The embodiments and descriptions in the specification are merely illustrative of the principles of the invention. Various changes and modifications can be made to the invention without departing from its spirit and scope, and all such changes and modifications fall within the scope of the present invention as claimed. The scope of protection of this invention is defined by the appended claims and their equivalents.

Claims

1. A device for administering a lupus erythematosus treatment drug, comprising a device body (1), characterized in that: A syringe (4) is inserted into the right side of the inner cavity of the device body (1). A loading component (5) is fixedly connected to the right side of the back of the device body (1). Limiting components (8) are symmetrically and movably connected to the top and bottom of the back of the inner cavity of the loading component (5). Movable blocks (11) are symmetrically and fixedly connected to the center of the back of the two limiting components (8). A medicine box (13) is fixedly connected to the left side of the back of the inner cavity of the device body (1), and a grinding component (14) is movably connected to the left side of the top of the device body (1). A pinhole groove (19) is opened on the left side of the front of the device body (1), and a baffle (18) is movably connected to the front of the pinhole groove (19). A threaded post (6) is fixedly connected to the center of the front of the loading assembly (5). The threaded post (6) is threaded to the back of the device body (1). Both the loading assembly (5) and the threaded post (6) are hollow structures. The back of the syringe (4) is located in the inner cavity of the loading assembly (5). Two movable blocks (11) are symmetrically and movably connected to the top and bottom of the back of the loading assembly (5). A bidirectional lead screw (12) is rotatably connected to the back of the loading assembly (5). A rotating handle (7) is fixedly connected to the top of the bidirectional lead screw (12). The rotating handle (7) is rotatably connected to the back of the top of the loading assembly (5). The two movable blocks (11) are symmetrically threaded to the top and bottom of the outer wall of the bidirectional lead screw (12).

2. The device for administering a lupus erythematosus treatment drug according to claim 1, characterized in that: Two limiting components (8) are symmetrically fixed with Velcro (9) on opposite sides, and two Velcro (9) are symmetrically attached with disinfectant wipes (10) on opposite sides. Two disinfectant wipes (10) are symmetrically attached to the back of the top and bottom of the outer wall of the syringe (4) on opposite sides.

3. The device for administering a lupus erythematosus treatment drug according to claim 1, characterized in that: The top of the medicine box (13) is movably connected to a lid, which is fastened to the top of the device body (1) by a latch. A buzzer (2) is fixedly connected to the front right side of the device body (1), and a timer (3) is fixedly connected to the back right side of the device body (1). A movable column (15) is fixedly connected to the center of the bottom of the grinding assembly (14), and a grinding disc (16) is fixedly connected to the bottom of the movable column (15). The grinding disc (16) is movably connected to the left side of the inner cavity of the device body (1), and a medicine inlet is provided on the left side of the device body (1).

4. The device for administering a lupus erythematosus treatment drug according to claim 1, characterized in that: A pull ring (17) is fixedly connected to the center of the left side of the baffle (18). A groove is provided on the left side of the front of the device body (1). The baffle (18) is movably connected in the inner cavity of the groove. The pinhole slot (19) is opened in the groove. Moving slots (20) are symmetrically provided in the center of the top and bottom of the inner cavity of the groove. Guide posts (21) are symmetrically fixedly connected in the center of the inner cavity of the two moving slots (20). Springs (22) are symmetrically wound around the outer walls of the two guide posts (21). The right side of the springs (22) is fixedly connected to the right side of the inner cavity of the moving slots (20). The right sides of the top and bottom of the baffle (18) are symmetrically movably connected in the inner cavity of the two moving slots (20) and sleeved on the outer walls of the two guide posts (21). The left sides of the two springs (22) are symmetrically fixedly connected to the top and bottom of the right side of the baffle (18).

Images